Citation

Leckband SG, McCarthy M, Kelsoe JR. Ment. Health Clin. 2012; 1(9): 217-221.

Copyright

(Copyright © 2012, College of Psychiatric and Neurologic Pharmacists)

DOI

10.9740/mhc.n99509

PMID

unavailable

Abstract

Bipolar Disorder (BD) is a common psychiatric illness that has a recurring course and 17% - 24% lifetime prevalence of suicide attempts. Difficulty in diagnosis and individual variation in response point to a great need for personalized medicine. Studies to date have focused largely on lithium and suggest the idea that different medication responses may reflect different disease mechanisms. An overview of current pharmacogenomic studies will be presented and needs and future directions discussed. © 2012 by the authors.

Language: en

Keywords

bipolar disorder; mood stabilizer; pharmacogenomics